- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 475/00 - Heterocyclic compounds containing pteridine ring systems
Patent holdings for IPC class C07D 475/00
Total number of patents in this class: 177
10-year publication summary
|
9
|
15
|
12
|
12
|
13
|
8
|
12
|
14
|
10
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4486 |
11 |
| Vertex Pharmaceuticals Incorporated | 1579 |
9 |
| Amgen Inc. | 4440 |
8 |
| Blueprint Medicines Corporation | 258 |
8 |
| East China University of Science and Technology | 555 |
7 |
| Vigil Neuroscience, Inc. | 54 |
6 |
| Astex Therapeutics Limited | 207 |
4 |
| Chroma Therapeutics Ltd. | 29 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2666 |
4 |
| Janus Biotherapeutics, Inc. | 10 |
4 |
| Abbisko Therapeutics Co., Ltd. | 119 |
4 |
| Pfizer Inc. | 3409 |
3 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 229 |
3 |
| Gilead Sciences, Inc. | 2236 |
3 |
| Signal Pharmaceuticals, LLC | 176 |
3 |
| Yale University | 2557 |
3 |
| Uppthera Inc. | 24 |
3 |
| Genentech, Inc. | 4114 |
2 |
| University of Florida Research Foundation, Inc. | 4188 |
2 |
| Purdue Research Foundation | 3937 |
2 |
| Other owners | 84 |